Shenzhen - Delayed Quote CNY
BGI Genomics Co., Ltd. (300676.SZ)
51.80
-0.98
(-1.86%)
At close: 3:04:22 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,717,580.54
3,866,920.76
4,349,637.25
7,053,150.77
6,766,137.32
Cost of Revenue
2,225,314.15
2,263,225.01
2,179,030.52
3,366,226.13
2,835,422.58
Gross Profit
1,492,266.39
1,603,695.76
2,170,606.74
3,686,924.64
3,930,714.73
Operating Expense
2,002,027.98
2,012,923.73
1,939,256.60
2,435,251.06
2,083,095.58
Operating Income
-509,761.59
-409,227.98
231,350.13
1,251,673.58
1,847,619.15
Net Non Operating Interest Income Expense
86,702.35
69,425.50
57,239.95
10,649.83
-64,497.47
Pretax Income
-971,470.36
-886,114.79
115,535.54
1,006,792.37
1,745,893.43
Tax Provision
8,076.39
25,986.29
21,853.69
197,506.82
268,194.83
Net Income Common Stockholders
-967,788.50
-902,690.86
92,900.40
802,765.41
1,461,536.27
Basic EPS
-2.35
-2.19
0.23
1.96
3.56
Diluted EPS
-2.35
-2.19
0.23
1.96
3.55
Basic Average Shares
413,126.09
412,375.91
409,975.27
410,369.80
410,048.61
Diluted Average Shares
413,126.09
412,375.91
412,340.86
408,386.53
411,677.17
Total Operating Income as Reported
-959,832.57
-874,767.76
150,649.19
1,087,910.17
1,822,834.80
Rent Expense Supplemental
--
3,533.17
2,195.04
2,144.99
7,513.86
Total Expenses
4,227,342.13
4,276,148.74
4,118,287.12
5,801,477.19
4,918,518.17
Net Income from Continuing & Discontinued Operation
-967,788.50
-902,690.86
92,900.40
802,765.41
1,461,536.27
Normalized Income
-680,555.18
-548,501.84
196,581.60
1,188,332.99
1,541,338.50
Interest Income
116,043.67
125,718.63
152,042.83
116,832.04
44,344.89
Interest Expense
37,157.43
52,019.19
91,560.41
100,764.22
104,716.37
Net Interest Income
86,702.35
69,425.50
57,239.95
10,649.83
-64,497.47
EBIT
-934,312.93
-834,095.60
207,095.95
1,107,556.59
1,850,609.81
EBITDA
-934,312.93
-350,567.07
643,932.07
1,560,622.49
2,221,210.40
Reconciled Cost of Revenue
2,225,314.15
2,263,225.01
2,179,030.52
3,366,226.13
2,835,422.58
Reconciled Depreciation
--
483,528.53
436,836.12
453,065.90
370,600.60
Net Income from Continuing Operation Net Minority Interest
-967,788.50
-902,690.86
92,900.40
802,765.41
1,461,536.27
Total Unusual Items Excluding Goodwill
-478,722.20
-472,252.02
-127,867.50
-479,665.68
-94,285.93
Total Unusual Items
-478,722.20
-472,252.02
-127,867.50
-479,665.68
-94,285.93
Normalized EBITDA
-455,590.73
121,684.95
771,799.58
2,040,288.17
2,315,496.34
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-191,488.88
-118,063.01
-24,186.30
-94,098.10
-14,483.70
12/31/2021 - 7/14/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade